Canada approves Pfizer COVID drug

ABC US News

18 January 2022 - Canada’s health regulator has approved a pill by Pfizer that treats the effects of COVID-19.

Health Canada authorised Paxlovid for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. 

Health Canada did not authorise it for use on teenagers or on patients who are already hospitalised because of COVID-19.

Read ABC News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Canada , COVID-19